An article in this week's PLoS Medicine describes the African AIDS Vaccine Programme (AAVP), which was established in 2000. The AAVP is a network of African HIV vaccine stakeholders, led by Africans across the continent, with a vision of "an AIDS-free Africa through an effective vaccine."
Pontiano Kaleebu (Uganda Virus Research Institute, Entebbe, Uganda) and colleagues describe what AAVP is, what it does, and the network's impact, successes, and challenges to date. "AAVP supports and represents the diverse African communities involved in HIV vaccine research and development," say the authors, "and is an important unified voice for African stakeholders."
Citation: Kaleebu P, Abimiku A, El-Halabi S, Koulla-Shiro S, Mamotte N, et al. (2008) African AIDS Vaccine Programme for a coordinated and collaborative vaccine development effort on the continent. PLoS Med 5(12): e236. doi:10.1371/journal.pmed.0050236
IN YOUR COVERAGE PLEASE USE THIS URL TO PROVIDE ACCESS TO THE FREELY AVAILABLE PAPER: http://medicine.plosjournals.org/perlserv/?request=get-document&doi=10.1371/journal.pmed.0050236
PRESS-ONLY PREVIEW OF THE ARTICLE: http://www.plos.org/press/plme-05-12-kaleebu.pdf
CONTACT:
Pontiano Kaleebu
MRC/UVRI Uganda Research Unit on AIDS
Immunology & Basic Sciences
Plot 51-57 Nakiwogo Road
Entebbe, Entebbe EBB
Uganda
+256- 414 320809 (institute)
+256-772 500 905 (cell)
+256-414-321127 (fax)
pontiano.kaleebu@mrcuganda.org
PLOS Medicine